Yue Li

Title: Yue Li - Innovator in Enzymatic Catalysis

Introduction

Yue Li is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of enzymatic catalysis, particularly in the preparation of immobilized arginine deiminase (ADI). Her innovative work has led to advancements in the production of [N]-L-citrulline, a compound with various applications in biochemistry and medicine.

Latest Patents

Yue Li holds a patent for a method that involves preparing immobilized arginine deiminase (ADI) and producing [N]-L-citrulline. The patent details the use of a genetically engineered fusion protein, cipA-arc, which has a deposit number of CGMCC No. 19404. This genetically engineered strain and the fusion protein can effectively convert [N]-L-arginine into [N]-L-citrulline through enzymatic catalysis.

Career Highlights

Throughout her career, Yue Li has worked with notable institutions, including the Shanghai University of Medicine & Health Sciences and Shanghai United Imaging Healthcare Co., Ltd. Her work in these organizations has allowed her to collaborate with other experts in the field and contribute to significant research projects.

Collaborations

Yue Li has collaborated with esteemed colleagues such as Gang Huang and Bin Li. These partnerships have enhanced her research and innovation efforts, leading to impactful advancements in her area of expertise.

Conclusion

Yue Li's contributions to enzymatic catalysis and her innovative patent demonstrate her commitment to advancing scientific knowledge and applications. Her work continues to influence the field and inspire future research endeavors.